Dive Into Dollar Tr...
Health Care: Drugs
Spectrum Pharmaceuticals Inc (SPPI: NASDAQ)
$8.14 0.06 | 0.74%
05/17/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with SPPI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- UserStock/ETF
- ContributorHeavily Shorted Market Lead...
- ContributorHot Biotech Trades for Seco...
Latest SPPI Headlines from TheStreet
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Dumbest Things 'April Fools' Quiz 03.29.13 | 07:03 am
- TheStreet Ratings Top 10 Rating Changes 03.25.13 | 01:03 pm
- Spectrum Pharmaceuticals Inc Stock Downgraded (SPPI) 03.20.13 | 05:03 am
- Healthcare Sector: High Quality Stocks At A Great Value 03.18.13 | 02:03 pm
- 5 Dumbest Things on Wall Street This Week: March 15 03.15.13 | 07:03 am
- The 5 Dumbest Things on Wall Street: March 15
03.15.13 | 05:03 am - Dow Gains for 9th day as IBM Jumps Into Record Territory 03.13.13 | 06:03 pm
- Spectrum Blames Fusilev Sales Warning on Overstuffed Inventory 03.13.13 | 10:03 am
- Stock Futures Turn Higher After Retail Sales Data 03.13.13 | 09:03 am
Press Releases for SPPI
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Spectrum Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of May 13, 2013 To Seek A Lead Plaintiff Position - PR Newswire 05.07.13 | 02:05 pm
- Abraham, Fruchter & Twersky, LLP Announces That A Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.22.13 | 12:03 pm
- Lifshitz Law Firm Announces Investigation Of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., And Tech Data Corporation - PR Newswire 03.22.13 | 11:03 am
- Hagens Berman Notifies Spectrum Pharmaceuticals Investors Of Pending Class-Action Lawsuit And May 13, 2013, Lead Plaintiff Deadline - Business Wire 03.22.13 | 09:03 am
- Spectrum Pharmaceuticals, Inc. Sued By Shareholders - PR Newswire 03.21.13 | 07:03 pm
- Spectrum Pharmaceuticals Shareholder Alert: Briscoe Law And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors - Business Wire 03.21.13 | 10:03 am
- Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, As Chief Medical Officer - Business Wire 03.18.13 | 07:03 am
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.15.13 | 04:03 pm
- Ryan & Maniskas, LLP Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. - PR Newswire 03.15.13 | 03:03 pm
- Spectrum Pharmaceuticals To Present Corporate Update At The 25th Annual ROTH Conference In Laguna Niguel On March 20th - Business Wire 03.15.13 | 07:03 am
Partner Headlines for SPPI
- This Drug Market Could Expand 80-Fold by 2020 - NASDAQ 10.17.12 | 01:10 pm
- SPPI a Step Closer to Allos - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- Spectrum Extends Allos Buyout Offer - Analyst Blog - NASDAQ 08.21.12 | 02:08 pm
- Notable Small-Cap Insider Sells Filed On August 16 - Seeking Alpha 08.17.12 | 09:08 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics - Benzinga 07.20.12 | 06:07 pm
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
- Kraft Hits a SELECT LIST and 4 Stocks with New Analyst Insights Now - Wall St. Cheat Sheet 07.02.12 | 01:07 pm
- Spectrum Extends Allos Tender Offer - Analyst Blog - Zacks 06.25.12 | 10:06 am
